IREN Limited
IREN
$26.19
$0.040.15%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 167.65% | 125.10% | 129.25% | 119.39% | 152.01% |
| Total Other Revenue | -- | 518.36% | 440.80% | -- | -- |
| Total Revenue | 167.65% | 127.30% | 130.59% | 121.13% | 152.01% |
| Cost of Revenue | 82.61% | 391.73% | 425.72% | 418.67% | 394.03% |
| Gross Profit | 241.60% | 91.78% | 80.62% | 52.94% | 76.72% |
| SG&A Expenses | 93.37% | 17.84% | 14.24% | 9.77% | 17.15% |
| Depreciation & Amortization | 258.90% | 371.36% | 290.20% | 147.75% | 53.40% |
| Other Operating Expenses | 366.67% | -40.98% | -66.80% | -81.94% | -109.43% |
| Total Operating Expenses | 132.49% | 111.59% | 99.92% | 80.25% | 63.85% |
| Operating Income | 205.70% | 56.09% | 15.20% | -0.38% | 62.46% |
| Income Before Tax | 467.13% | -370.57% | -112.13% | 54.93% | 89.11% |
| Income Tax Expenses | 89.92% | 191.83% | 6,659.32% | 407.12% | 257.56% |
| Earnings from Continuing Operations | 400.61% | -304.27% | -149.80% | 52.69% | 87.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 400.61% | -304.27% | -149.80% | 52.69% | 87.69% |
| EBIT | 205.70% | 56.09% | 15.20% | -0.38% | 62.46% |
| EBITDA | 551.62% | 823.63% | 1,433.56% | 249.38% | 245.94% |
| EPS Basic | 229.32% | -28.78% | 13.72% | 85.07% | 94.31% |
| Normalized Basic EPS | 267.12% | 56.87% | 75.79% | 70.65% | 84.30% |
| EPS Diluted | 207.95% | -28.73% | 13.72% | 85.03% | 94.27% |
| Normalized Diluted EPS | 248.07% | 56.87% | 75.79% | 70.65% | 84.30% |
| Average Basic Shares Outstanding | 112.29% | 149.43% | 165.28% | 128.35% | 84.54% |
| Average Diluted Shares Outstanding | 120.85% | 149.43% | 165.28% | 128.35% | 84.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |